Integra Lifesciences Holdings (IART) Total Liabilities (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Total Liabilities of $2.5 billion for Q2 2026, down 0.6% sequentially from $2.5 billion in Q1 2026, and down 4.15% YoY from $2.6 billion in Q2 2025.
Integra Lifesciences Holdings (IART) Total Liabilities (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Total Liabilities for 18 years, with the latest figure at $2.5 billion in Q2 2026.
- Quarterly Total Liabilities fell 4.15% year-over-year to $2.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.5 billion (down 4.15% YoY) and the FY2025 annual result came in at $2.6 billion, up 2.66% from the prior year.
- Total Liabilities slipped to $2.5 billion in Q2 2026 per IART's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $2.6 billion in Q2 2025 and troughed at $2.1 billion in Q1 2022.
- A 5-year average of $2.3 billion and a median of $2.5 billion in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities retreated 7.03% in 2022, then gained 21.29% in 2024.
- Over 5 years, Total Liabilities stood at $2.1 billion in 2022, then grew by 5.21% to $2.2 billion in 2023, then grew by 13.58% to $2.5 billion in 2024, then gained by 2.66% to $2.6 billion in 2025, then slipped by 1.5% to $2.5 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.5 billion, $2.5 billion, and $2.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Bn |
| Mar 31, 2026 | 2.54 Bn |
| Dec 31, 2025 | 2.56 Bn |
| Sep 30, 2025 | 2.61 Bn |
| Jun 30, 2025 | 2.63 Bn |
| Mar 31, 2025 | 2.53 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.54 Bn |
| Jun 30, 2024 | 2.54 Bn |
| Mar 31, 2024 | 2.48 Bn |
| Dec 31, 2023 | 2.19 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 2.07 Bn |
| Dec 31, 2022 | 2.09 Bn |
| Sep 30, 2022 | 2.08 Bn |
| Jun 30, 2022 | 2.09 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.10 Bn |
| Sep 30, 2021 | 2.14 Bn |